US Stock MarketDetailed Quotes

INMB INmune Bio

Watchlist
  • 10.490
  • +0.570+5.75%
Close May 14 16:00 ET
207.52MMarket Cap-5463P/E (TTM)

About INmune Bio Company

INmune Bio, Inc. Is a clinical stage biotechnology company, which engages in developing new immunotherapies that reprograms the immune system to fight cancer and Alzheimer’s disease. Its products include pipeline, INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer and TRD, and LIVNate. The company was founded by Mark Lowdell in September 2015 and is headquartered in Boca Raton, FL.

Company Profile

SymbolINMB
Company NameINmune Bio
Listing DateFeb 4, 2019
Issue Price8.00
Founded2015
CEODr. Raymond J. Tesi, M.D.
MarketNASDAQ
Employees17
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address225 NE Mizner Boulevard,Suite 640
CityBoca Raton
ProvinceFlorida
CountryUnited States of America
Zip Code33432
Phone1-858-964-3720
Websitehttp://www.inmunebio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Raymond J. Tesi, M.D.
  • Chairman of the Board, President and Chief Executive Officer
  • 1.44M
  • David J. Moss
  • Principal Accounting Officer, Chief Financial Officer, Treasurer and Secretary
  • 1.30M
  • Dr. Mark Lowdell, PhD
  • Chief Scientific Officer
  • 904.60K
  • Timothy (Tim) Schroeder
  • Independent Director
  • 250.00K
  • Dr. Edgardo Baracchini,PhD
  • Independent Director
  • 250.00K
  • Marcia Allen
  • Independent Director
  • 250.00K
  • Scott Juda, J.D.
  • Independent Director
  • 250.00K
  • J. Kelly Ganjei
  • Independent Director
  • 250.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg